The Urinary Glucose Excretion by Sodium–Glucose Cotransporter 2 Inhibitor in Patients With Different Levels of Renal Function: A Systematic Review and Meta-Analysis

OBJECTIVE: Previous evidence suggested that sodium–glucose cotransporter 2 inhibitor (SGLT2i)-mediated urinary glucose excretion (UGE) appeared to be reduced with a decrease in glomerular filtration rate. Thus, we conducted a systematic review and meta‐analysis to compare SGLT2i-mediated UGE among i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Suiyuan, Lin, Chu, Cai, Xiaoling, Zhu, Xingyun, Lv, Fang, Nie, Lin, Ji, Linong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830597/
https://www.ncbi.nlm.nih.gov/pubmed/35154011
http://dx.doi.org/10.3389/fendo.2021.814074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830597/
https://www.ncbi.nlm.nih.gov/pubmed/35154011
http://dx.doi.org/10.3389/fendo.2021.814074

Ejemplares similares